Classification and Diagnostic Criteria for IgG4-Related Sclerosing Cholangitis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
IgG4-related sclerosing cholangitis (IgG4-SC) can be classified into four types based on cholangiographic findings and regions of biliary stricture. This cholangiographic classification is useful to differentiate IgG4-SC from mimickers including cholangiocarcinoma, primary sclerosing cholangitis, and pancreatic cancer. Autoimmune pancreatitis (AIP) is a valuable clue for the diagnosis of IgG4-SC because the two are frequently found in association with each other. Two sets of diagnostic criteria for IgG4-SC have been proposed. In Japan, the clinical diagnostic criteria 2020 were recently developed. These clinical diagnostic criteria include narrowing of the intrahepatic and/or extrahepatic bile duct, thickening of the bile duct wall, serological findings, pathological findings, other organ involvement, and effectiveness of steroid therapy. When these criteria are applied, IgG4-SC is initially classified as associated or not associated with AIP, and cholangiographic classification is used for differential diagnosis. In most instances, IgG4-SC can be diagnosed on the basis of clinical diagnostic criteria. However, it is challenging to diagnose isolated IgG4-SC or IgG4-SC not associated with AIP. Here, we review the classification and diagnostic criteria for IgG4-SC, specifically focusing on the clinical diagnostic criteria 2020 and a large IgG4- SC case series from a nationwide survey in Japan.
Abstract
IgG4-related sclerosing cholangitis (IgG4-SC) can be classified into four types based on cholangiographic findings and regions of biliary stricture. This cholangiographic classification is useful to differentiate IgG4-SC from mimickers including cholangiocarcinoma, primary sclerosing cholangitis, and pancreatic cancer. Autoimmune pancreatitis (AIP) is a valuable clue for the diagnosis of IgG4-SC because the two are frequently found in association with each other. Two sets of diagnostic criteria for IgG4-SC have been proposed. In Japan, the clinical diagnostic criteria 2020 were recently developed. These clinical diagnostic criteria include narrowing of the intrahepatic and/or extrahepatic bile duct, thickening of the bile duct wall, serological findings, pathological findings, other organ involvement, and effectiveness of steroid therapy. When these criteria are applied, IgG4-SC is initially classified as associated or not associated with AIP, and cholangiographic classification is used for differential diagnosis. In most instances, IgG4-SC can be diagnosed on the basis of clinical diagnostic criteria. However, it is challenging to diagnose isolated IgG4-SC or IgG4-SC not associated with AIP. Here, we review the classification and diagnostic criteria for IgG4-SC, specifically focusing on the clinical diagnostic criteria 2020 and a large IgG4- SC case series from a nationwide survey in Japan.
참고문헌 (40)
- Kamisawa T, "A new clinicopathological entity of IgG4-related autoimmune disease", J Gastroenterol, 38, pp.982~984 (2003)
- Umehara H, "Comprehensive diagnostic criteria for IgG4-related disease(IgG4-RD), 2011", Mod Rheumatol, 22, pp.21~30 (2012)
- Kamisawa T, "IgG4-related disease", Lancet, 385, pp.1460~1471 (2015)
- Ohara H, "Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012", J Hepatobiliary Pancreat Sci, 19, pp.536~542 (2012)
- Nakazawa T, "IgG4-related sclerosing cholangitis", Semin Liver Dis, 36, pp.216~228 (2016)
- Kamisawa T, "Clinical practice guidelines for IgG4-related sclerosing cholangitis", J Hepatobiliary Pancreat Sci, 26, pp.9~42 (2019)
- Tanaka A, "Clinical features, response to treatment, and outcomes of IgG4-related sclerosing cholangitis", Clin Gastroenterol Hepatol, 15, pp.920~926 (2017)
- Atsushi Tanaka, "IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis", Gut and Liver, 13(3), pp.300~307 (2019), 거트앤리버 소화기연관학회협의회[DOI]
- Tanaka A, "Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan", J Hepatobiliary Pancreat Sci, 21, pp.43~50 (2014)
- Isayama H, "Clinical guidelines for primary sclerosing cholangitis 2017", J Gastroenterol, 53, pp.1006~1034 (2018)
- Chapman MH, "British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis", Gut, 68, pp.1356~1378 (2019)
- Graham RP, "Isolated IgG4-related sclerosing cholangitis : a report of 9cases", Hum Pathol, 45, pp.1722~1729 (2014)
- Nakazawa T, "Isolated intrapancreatic IgG4-related sclerosing cholangitis", World J Gastroenterol, 21, pp.1334~1343 (2015)
- Takagi Y, "Clinical features of isolated proximal-type immunoglobulin G4-related sclerosing cholangitis", Dig Endosc, 31, pp.422~430 (2019)
- Nakazawa T, "Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography", Pancreas, 32, pp.229~ (2006)
- Ghazale A, "Immunoglobulin G4-associated cholangitis : clinical profile and response to therapy", Gastroenterology, 134, pp.706~715 (2008)
- Nakazawa T, "Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification", J Gastroenterol, 47, pp.79~87 (2012)
- Nakazawa T, "Diagnosis of IgG4-related sclerosing cholangitis", World J Gastroenterol, 19, pp.7661~7670 (2013)
- Nakazawa T, "Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020 : (revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012)", J Hepatobiliary Pancreat Sci, 28, pp.235~242 (2021)
- Naitoh I, "Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis:comparison of cases with and without autoimmune pancreatitis in a large cohort", Dig Liver Dis, 53, pp.1308~1314 (2021)
- Bochatay L, "Isolated liver hilar infiltration by IgG4 inflammation mimicking cholangiocarcinoma", Case Rep Gastroenterol, 10, pp.512~517 (2016)
- Ohara H, "Establishment of a serum IgG4 cut-offvalue for the differential diagnosis of IgG4-related sclerosing cholangitis : a Japanese cohort", J Gastroenterol Hepatol, 28, pp.1247~1251 (2013)
- Nakazawa T, "Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis", Gastrointest Endosc, 60, pp.937~944 (2004)
- Nishino T, "Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis", J Gastroenterol, 42, pp.550~559 (2007)
- Naitoh I, "Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis", J Gastroenterol, 44, pp.1147~1155 (2009)
- Kubota K, "Discrimination between sclerosing cholangitis-associated autoimmune pancreatitis and primary sclerosing cholangitis, cancer using intraductal ultrasonography", Dig Endosc, 23, pp.10~16 (2011)
- Moon SH, "The role of endoscopy in the diagnosis of autoimmune pancreatitis", Gastrointest Endosc, 76, pp.645~656 (2012)
- Kamisawa T, "Role of endoscopy in the diagnosis of autoimmune pancreatitis and immunoglobulin G4-related sclerosing cholangitis", Dig Endosc, 26, pp.627~635 (2014)
- Kanno A, "Endoscopic approaches for the diagnosis of autoimmune pancreatitis", Dig Endosc, 27, pp.250~258 (2015)
- Naitoh I, "Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4-related sclerosing cholangitis", J Gastroenterol Hepatol, 30, pp.1104~1109 (2015)
- Oseini AM, "Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma", Hepatology, 54, pp.940~948 (2011)
- Boonstra K, "Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis", Hepatology, 59, pp.1954~1963 (2014)
- Hamano H, "Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma : part of a spectrum of autoimmune pancreatitis?", Gastrointest Endosc, 62, pp.152~157 (2005)
- Hirano K, "Diagnostic utility of biopsy specimens for autoimmune pancreatitis", J Gastroenterol, 44, pp.765~773 (2009)
- Kawakami H, "IgG4-related sclerosing cholangitis and autoimmune pancreatitis : histological assessment of biopsies from Vater's ampulla and the bile duct", J Gastroenterol Hepatol, 25, pp.1648~1655 (2010)
- Kamisawa T, "A new diagnostic endoscopic tool for autoimmune pancreatitis", Gastrointest Endosc, 68, pp.358~361 (2008)
- Kubota K, "Differentiating sclerosing cholangitis caused by autoimmune pancreatitis and primary sclerosing cholangitis according to endoscopic duodenal papillary features", Gastrointest Endosc, 68, pp.1204~1208 (2008)
- Yamashita H, "A comparison of the diagnostic efficacy in type 1 autoimmune pancreatitis based on biopsy specimens from various organs", Pancreatology, 14, pp.186~192 (2014)
- Moon SH, "IgG4 immunostaining of duodenal papillary biopsy specimens may be useful for supporting a diagnosis of autoimmune pancreatitis", Gastrointest Endosc, 71, pp.960~966 (2010)
- Shimosegawa T, "International consensus diagnostic criteria for autoimmune pancreatitis : guidelines of the International Association of Pancreatology", Pancreas, 40, pp.352~358 (2011)
